Advanced search
Publication Cover
Journal of Blood Medicine Volume 14, 2023 - Issue
Submit an article Journal homepage
129
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Hyperviscosity Syndrome Induced Bilateral Visual and Auditory Impairment in Therapy Resistant Waldenström Macroglobulinemia with MYD88 and CXCR4 Mutations

Marie M Plante1 Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA
,
ErinMarie O Kimbrough2 Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USAORCID Iconhttps://orcid.org/0009-0007-8621-3638
ORCID Icon,
Amit K Agarwal3 Department of Radiology, Mayo Clinic, Jacksonville, FL, USA
,
Liuyan Jiang4 Department of Pathology, Mayo Clinic, Jacksonville, FL, USAORCID Iconhttps://orcid.org/0000-0002-9851-985X
ORCID Icon,
Kirk Bourgeois4 Department of Pathology, Mayo Clinic, Jacksonville, FL, USA
,
Greta C Stamper5 Department of Otolaryngology and Audiology, Mayo Clinic, Jacksonville, FL, USA
,
Michael W Stewart6 Department of Ophthalmology, Mayo Clinic, Jacksonville, FL, USA
&
Han W Tun2 Division of Hematology and Oncology, Mayo Clinic, Jacksonville, FL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-9184-094X
ORCID Icon show all
Pages 639-648 | Received 02 Jun 2023, Accepted 21 Nov 2023, Published online: 15 Dec 2023

References

  • Waldenström JG. Macroglobulinemia--a review. Haematologica. 1986;71(6):437–440.
  • Groves FD, Travis LB, Devesa SS, et al. Waldenström’s macroglobulinemia: incidence patterns in the United States, 1988–1994. Cancer. 1998;82(6):1078–1081. doi:10.1002/(SICI)1097-0142(19980315)82:6<1078::AID-CNCR10>3.0.CO;2-3
  • Swerdlow SH, Campo E, Pileri SA, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–2390. doi:10.1182/blood-2016-01-643569
  • Varettoni M, Ferrari A, Frustaci AM, et al. Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies. Am J Hematol. 2020;95(12):1473–1478. doi:10.1002/ajh.25961
  • Stone MJ, Bogen SA. Role of plasmapheresis in Waldenström’s macroglobulinemia. Clin Lymphoma Myeloma Leuk. 2013;13(2):238–240. doi:10.1016/j.clml.2013.02.013
  • Gertz MA. Acute hyperviscosity: syndromes and management. Blood. 2018;132(13):1379–1385. doi:10.1182/blood-2018-06-846816
  • Gertz MA. Waldenstrom Macroglobulinemia: tailoring therapy for the individual. J Clin Oncol. 2022;40(23):2600–2608. doi:10.1200/JCO.22.00495
  • Schwartz J, Padmanabhan A, Aqui N, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the Seventh Special Issue. J Clin Apher. 2016;31(3):149–162. doi:10.1002/jca.21470
  • Stone MJ, Bogen SA. Evidence-based focused review of management of hyperviscosity syndrome. Blood. 2012;119(10):2205–2208. doi:10.1182/blood-2011-04-347690
  • Shrestha S, Poddar E, Bashyal B, et al. Bilateral central retinal vein occlusion as an initial presentation of Waldenström macroglobulinemia: a case report. J Med Case Rep. 2023;17(1):59. doi:10.1186/s13256-023-03778-4
  • Gustine JN, Meid K, Dubeau T, et al. Serum IgM level as predictor of symptomatic hyperviscosity in patients with Waldenström macroglobulinemia. Br J Haematol. 2017;177(5):717–725. doi:10.1111/bjh.14743
  • Castillo JJ, Moreno DF, Arbelaez MI, et al. CXCR4 mutations affect presentation and outcomes in patients with Waldenström macroglobulinemia: a systematic review. Expert Rev Hematol. 2019;12(10):873–881. doi:10.1080/17474086.2019.1649132
  • Kiew S, Ting D. Diagnosis and management of central retinal vein occlusion. EyeNet Magazine; 2018.
  • Baker PS, Garg SJ, Fineman MS, et al. Serous macular detachment in Waldenström macroglobulinemia: a report of four cases. Am J Ophthalmol. 2013;155(3):448–455. doi:10.1016/j.ajo.2012.09.018
  • Leskov I, Knezevic A, Gill MK. Serous macular detachment associated with Waldenstrom macroglobulinemia managed with ibrutinib: a case report and new insights into pathogenesis. Retin Cases Brief Rep. 2021;15(4):490–494. doi:10.1097/ICB.0000000000000837
  • Watson JA, Olson DJ, Zhang AY. Hyperviscosity retinopathy due to waldenström macroglobulinemia: a case report and literature review. J Vitreoretin Dis. 2021;5(6):520–524. doi:10.1177/2474126420987142
  • Ershler W. Waldenström macroglobulinemia with hyperviscosity: illustrative case series. Relias Media; 2012.
  • Sedhom R. View of Waldenstrom’s macroglobulinemia presenting as syncope. Global J Med Res. 2016;16(F5):17–18.
  • Menke MN, Feke GT, McMeel JW, Treon SP. Effect of plasmapheresis on hyperviscosity-related retinopathy and retinal hemodynamics in patients with Waldenstrom’s macroglobulinemia. Invest Ophthalmol Vis Sci. 2008;49(3):1157–1160. doi:10.1167/iovs.07-1254
  • Anderson KC, Alsina M, Bensinger W, et al. Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma, version 1.2023. Natl Compr Canc Netw. 2022;10(10):1211–1219.
  • Treon SP, Xu L, Guerrera ML, et al. Genomic landscape of Waldenström macroglobulinemia and its impact on treatment strategies. J Clin Oncol. 2020;38(11):1198–1208. doi:10.1200/JCO.19.02314
  • André F, Arnedos M, Baras AS; AACR Project GENIE Consortium. AACR project GENIE: powering precision medicine through an International Consortium. Cancer Discov. 2017;7(8):818–831. doi:10.1158/2159-8290.CD-17-0151

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.